CRISPR-based therapeutics: current challenges and future applications
Author:
Funder
National Institute of Health
National Institutes of Health
Defense Advanced Research Projects Agency
Broad Institute
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference102 articles.
1. RNA-guided human genome engineering via Cas9;Mali;Science,2013
2. Multiplex genome engineering using CRISPR/Cas systems;Cong;Science,2013
3. Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens;Behan;Nature,2019
4. Highly efficient Cas9-mediated transcriptional programming;Chavez;Nat. Methods,2015
5. Genome-scale CRISPR-mediated control of gene repression and activation;Gilbert;Cell,2014
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanotherapy for human papillomavirus-associated cancers: breakthroughs and challenges;Trends in Pharmacological Sciences;2024-09
2. Precision epigenetic editing: Technological advances, enduring challenges, and therapeutic applications;Cell Chemical Biology;2024-08
3. Current application and future perspective of CRISPR/cas9 gene editing system mediated immune checkpoint for liver cancer treatment;Nanotechnology;2024-07-17
4. Sorl1 knockout inhibits expression of brain-derived neurotrophic factor: involvement in the development of late-onset Alzheimer's disease;NEURAL REGEN RES;2024
5. Bioengineering toolkits for potentiating organoid therapeutics;Advanced Drug Delivery Reviews;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3